Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

Impact of antibiotic treatment and host innate immune pressure on enterococcal adaptation in the human bloodstream.

Van Tyne D, Manson AL, Huycke MM, Karanicolas J, Earl AM, Gilmore MS.

Sci Transl Med. 2019 Apr 10;11(487). pii: eaat8418. doi: 10.1126/scitranslmed.aat8418.

PMID:
30971455
2.

Staphylococcus aureus from ocular and otolaryngology infections are frequently resistant to clinically important antibiotics and are associated with lineages of community and hospital origins.

Wurster JI, Bispo PJM, Van Tyne D, Cadorette JJ, Boody R, Gilmore MS.

PLoS One. 2018 Dec 6;13(12):e0208518. doi: 10.1371/journal.pone.0208518. eCollection 2018.

3.

Molecular basis for the emergence of a new hospital endemic tigecycline-resistant Enterococcus faecalis ST103 lineage.

Dabul ANG, Avaca-Crusca JS, Navais RB, Merlo TP, Van Tyne D, Gilmore MS, Camargo ILBDC.

Infect Genet Evol. 2019 Jan;67:23-32. doi: 10.1016/j.meegid.2018.10.018. Epub 2018 Oct 25.

PMID:
30393188
4.

Long-Term Colonization Dynamics of Enterococcus faecalis in Implanted Devices in Research Macaques.

Lieberman MT, Van Tyne D, Dzink-Fox J, Ma EJ, Gilmore MS, Fox JG.

Appl Environ Microbiol. 2018 Aug 31;84(18). pii: e01336-18. doi: 10.1128/AEM.01336-18. Print 2018 Sep 15.

5.

Propyl-5-hydroxy-3-methyl-1-phenyl-1H-pyrazole-4-carbodithioate (HMPC): a new bacteriostatic agent against methicillin-resistant Staphylococcus aureus.

Johnston T, Van Tyne D, Chen RF, Fawzi NL, Kwon B, Kelso MJ, Gilmore MS, Mylonakis E.

Sci Rep. 2018 May 4;8(1):7062. doi: 10.1038/s41598-018-25571-w.

6.

A new class of synthetic retinoid antibiotics effective against bacterial persisters.

Kim W, Zhu W, Hendricks GL, Van Tyne D, Steele AD, Keohane CE, Fricke N, Conery AL, Shen S, Pan W, Lee K, Rajamuthiah R, Fuchs BB, Vlahovska PM, Wuest WM, Gilmore MS, Gao H, Ausubel FM, Mylonakis E.

Nature. 2018 Apr 5;556(7699):103-107. doi: 10.1038/nature26157. Epub 2018 Mar 28.

7.

Promysalin Elicits Species-Selective Inhibition of Pseudomonas aeruginosa by Targeting Succinate Dehydrogenase.

Keohane CE, Steele AD, Fetzer C, Khowsathit J, Van Tyne D, Moynié L, Gilmore MS, Karanicolas J, Sieber SA, Wuest WM.

J Am Chem Soc. 2018 Feb 7;140(5):1774-1782. doi: 10.1021/jacs.7b11212. Epub 2018 Jan 24.

8.

Identification of a Functionally Unique Family of Penicillin-Binding Proteins.

Welsh MA, Taguchi A, Schaefer K, Van Tyne D, Lebreton F, Gilmore MS, Kahne D, Walker S.

J Am Chem Soc. 2017 Dec 13;139(49):17727-17730. doi: 10.1021/jacs.7b10170. Epub 2017 Nov 30.

9.

Resistance in In Vitro Selected Tigecycline-Resistant Methicillin-Resistant Staphylococcus aureus Sequence Type 5 Is Driven by Mutations in mepR and mepA Genes.

Dabul ANG, Avaca-Crusca JS, Van Tyne D, Gilmore MS, Camargo ILBC.

Microb Drug Resist. 2018 Jun;24(5):519-526. doi: 10.1089/mdr.2017.0279. Epub 2017 Oct 17.

PMID:
29039719
10.

Raising the Alarmone: Within-Host Evolution of Antibiotic-Tolerant Enterococcus faecium.

Van Tyne D, Gilmore MS.

MBio. 2017 Feb 21;8(1). pii: e00066-17. doi: 10.1128/mBio.00066-17.

11.

High-Quality Draft Genome Sequence of the Multidrug-Resistant Clinical Isolate Enterococcus faecium VRE16.

de Mello SS, Van Tyne D, Dabul AN, Gilmore MS, Camargo IL.

Genome Announc. 2016 Sep 22;4(5). pii: e00992-16. doi: 10.1128/genomeA.00992-16.

12.

Novel Phagocytosis-Resistant Extended-Spectrum β-Lactamase-Producing Escherichia coli From Keratitis.

Van Tyne D, Ciolino JB, Wang J, Durand ML, Gilmore MS.

JAMA Ophthalmol. 2016 Nov 1;134(11):1306-1309. doi: 10.1001/jamaophthalmol.2016.3283.

13.

Virulence Plasmids of Nonsporulating Gram-Positive Pathogens.

Van Tyne D, Gilmore MS.

Microbiol Spectr. 2014 Oct;2(5). doi: 10.1128/microbiolspec.PLAS-0002-2013. Review.

14.

Plasmodium falciparum gene expression measured directly from tissue during human infection.

Van Tyne D, Tan Y, Daily JP, Kamiza S, Seydel K, Taylor T, Mesirov JP, Wirth DF, Milner DA Jr.

Genome Med. 2014 Nov 29;6(11):110. doi: 10.1186/s13073-014-0110-6. eCollection 2014.

15.

A delicate balance: maintaining mutualism to prevent disease.

Van Tyne D, Gilmore MS.

Cell Host Microbe. 2014 Oct 8;16(4):425-7. doi: 10.1016/j.chom.2014.09.019.

16.

Enrichment of reticulocytes from whole blood using aqueous multiphase systems of polymers.

Kumar AA, Lim C, Moreno Y, Mace CR, Syed A, Van Tyne D, Wirth DF, Duraisingh MT, Whitesides GM.

Am J Hematol. 2015 Jan;90(1):31-6. doi: 10.1002/ajh.23860. Epub 2014 Oct 18.

17.

Friend turned foe: evolution of enterococcal virulence and antibiotic resistance.

Van Tyne D, Gilmore MS.

Annu Rev Microbiol. 2014;68:337-56. doi: 10.1146/annurev-micro-091213-113003. Epub 2014 Jun 18. Review.

18.

Polymorphism in dhfr/dhps genes, parasite density and ex vivo response to pyrimethamine in Plasmodium falciparum malaria parasites in Thies, Senegal.

Ndiaye D, Dieye B, Ndiaye YD, Van Tyne D, Daniels R, Bei AK, Mbaye A, Valim C, Lukens A, Mboup S, Ndir O, Wirth DF, Volkman S.

Int J Parasitol Drugs Drug Resist. 2013 Aug 12;3:135-42. doi: 10.1016/j.ijpddr.2013.07.001. eCollection 2013 Dec.

19.

Changes in drug sensitivity and anti-malarial drug resistance mutations over time among Plasmodium falciparum parasites in Senegal.

Van Tyne D, Dieye B, Valim C, Daniels RF, Sène PD, Lukens AK, Ndiaye M, Bei AK, Ndiaye YD, Hamilton EJ, Ndir O, Mboup S, Volkman SK, Wirth DF, Ndiaye D.

Malar J. 2013 Dec 6;12:441. doi: 10.1186/1475-2875-12-441.

20.

Dual defensin strategy for targeting Enterococcus faecalis.

Gilmore MS, Lebreton F, Van Tyne D.

Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):19980-1. doi: 10.1073/pnas.1319939110. Epub 2013 Nov 27. No abstract available.

Supplemental Content

Loading ...
Support Center